How are one class of diabetes drugs related to cancer risk? Elizabeth Tracey reports
About this episode
The episode discusses the relationship between GLP-1 agonists, diabetes treatment, and their potential impact on obesity-related cancer risk.
GLP-1 agonists are a class of drugs originally developed to treat diabetes but have been shown to be helpful for weight loss. Now a new study looks at whether their use reduces the risk of obesity related cancers. William Nelson, … How are one class of diabetes drugs related to cancer risk? Elizabeth Tracey reports Read More »
More episodes of Health Newsfeed – Johns Hopkins Medicine Podcasts
- Several strategies seem to help in keeping mosquitoes out of your yard, Elizabeth Tracey reports
- Keeping your backyard barbecue free of mosquitoes is possible, Elizabeth Tracey reports
- How often can a blood test predict cancer risk? Elizabeth Tracey reports
- Will a blood test compel more people to be screened for lung cancer? Elizabeth Tracey reports
- Can a blood test improve lung cancer screening? Elizabeth Tracey reports
- What do false positives and negatives have to do with screening tests for cancer? Elizabeth Tracey reports
Explore listener stats, chart rankings, contacts and more on the Health Newsfeed – Johns Hopkins Medicine Podcasts podcast page.